Italian study tracks Real-Life use of powerful cholesterol drug
NCT ID NCT07375225
Summary
This study aims to see how well patients in Italy stick with and respond to a high-dose cholesterol medication called alirocumab in everyday life. It will enroll 1,500 adults already taking the drug to track their medication use and measure changes in their 'bad' cholesterol levels. The goal is to understand the real-world effectiveness and safety of this treatment for managing high cholesterol.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Federico II University of Naples, Department of Advanced Biomedical Sciences
RECRUITINGNapoli, Napoli, 80131, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.